Framework
A Trust Infrastructure for Global Medical Device Supply Chain
AimBios delivers a unified infrastructure designed to enhance transparency and provide clear risk state visibility across the global medical device supply chain.
Our platform integrates a blockchain-based record of transaction milestones, supports escrow-facilitated payment structures, and enables rule-based procurement agreements tailored for cross-border medical equipment transactions.
01 Blockchain-Based Transaction State & Rule-Execution Infrastructure
Key Capabilities
On-Chain Evidence Storage:
All key risk states in rule-based transaction structure are hashed and anchored on the blockchain for immutable verification.Real-World Asset (RWA) Risk Loop:
We validate every key event in the supply chain: 1. Real end-users & distributors & manufacturers 2. Real delivery 3. Real logistics 4. Real acceptance 5. Real repaymentAnti-Fraud Architecture
fake trades, circular trades, and fraudulent transactions—key risks for financial institutions entering cross-border medical device financing.Data-Driven Credit Insights (future)
Evolving toward Dynamic Credit scoring powered by verified trade activity in rule-based transaction.
02 Flexible Financing Structures
We support more efficient financing decision-support tool for cross-border medical equipment procurement through event-driven risk validation and configurable fund execution models.
Workflow
Benefits
For Manufacturers
1. Accelerated cash flow2. Reduced accounts receivable pressure3. Increased sales without adding processes or cost
For Financial Institutions
1. Funds remain fully controlled and verified in your owned account. 2. Trade events trigger financing actions (“event-driven risk state”)3. Every payout and repayment is fully monitorable and auditable4. Much lower exposure to non-real trades
For Distributors
1. Improved credit record profile in transaction state2. Possible access to financing under rule-based framework3. Increased the options for financing sales